Angiosarcoma clinical trials at UCSF

1 research study open to eligible people

Angiosarcoma is a cancer that affects the blood vessels. UCSF is researching new drugs to treat breast cancer by tailoring treatments to each patient. This research helps discover which medications are most effective for different individuals.

Showing trials for

  • I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

    San Francisco, California and other locations

Last updated: